High-flow Nasal Cannula Versus Noninvasive ventilation for Postextubation Acute Respiratory Failure after Pediatric Cardiac Surgery

Naohiro Shioji, Tomoyuki Kanazawa, Tatsuo Iwasaki, Kazuyoshi Shimizu, Tomohiko Suemori, Yasutoshi Kuroe, Hiroshi Morimatsu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We compared the reintubation rate in children who received high-flow nasal cannula (HFNC) therapy to the rate in children who received noninvasive ventilation (NIV) therapy for acute respiratory failure (ARF) after cardiac surgery. This was a retrospective analysis of 35 children who received HFNC therapy for ARF after cardiac surgery in 2014-2015 (the HFNC group). We selected 35 children who had received NIV therapy for ARF after cardiac surgery in 2009-2012 as a control group. The matching parameters were body weight and risk adjustment for congenital heart surgery category 1. The reintubation rate within 48 h in the HFNC group tended to be lower than that in the NIV group (3% vs. 17%, p=0.06). The reintubation rate within 28 days was significantly lower in the HFNC group compared to the NIV group (3% vs. 26%, p=0.04). The HFNC group's ICU stays were significantly shorter than those of the NIV group: 10 (IQR: 7-17) days vs. 17 (11-32) days, p=0.009. HFNC therapy might be associated with a reduced reintubation rate in children with ARF after cardiac surgery.

Original languageEnglish
Pages (from-to)15-20
Number of pages6
JournalActa medica Okayama
Volume73
Issue number1
DOIs
Publication statusPublished - Feb 1 2019

Fingerprint

Noninvasive Ventilation
Pediatrics
Respiratory Insufficiency
Surgery
Thoracic Surgery
Ventilation
Intensive care units
Risk Adjustment
Therapeutics
Cannula
Body Weight
Control Groups

Keywords

  • acute respiratory failure
  • congenital heart disease
  • high-flow nasal cannula
  • noninvasive ventilation
  • reintubation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

High-flow Nasal Cannula Versus Noninvasive ventilation for Postextubation Acute Respiratory Failure after Pediatric Cardiac Surgery. / Shioji, Naohiro; Kanazawa, Tomoyuki; Iwasaki, Tatsuo; Shimizu, Kazuyoshi; Suemori, Tomohiko; Kuroe, Yasutoshi; Morimatsu, Hiroshi.

In: Acta medica Okayama, Vol. 73, No. 1, 01.02.2019, p. 15-20.

Research output: Contribution to journalArticle

@article{f00ec5bc9c774efc83f6847849029dd2,
title = "High-flow Nasal Cannula Versus Noninvasive ventilation for Postextubation Acute Respiratory Failure after Pediatric Cardiac Surgery",
abstract = "We compared the reintubation rate in children who received high-flow nasal cannula (HFNC) therapy to the rate in children who received noninvasive ventilation (NIV) therapy for acute respiratory failure (ARF) after cardiac surgery. This was a retrospective analysis of 35 children who received HFNC therapy for ARF after cardiac surgery in 2014-2015 (the HFNC group). We selected 35 children who had received NIV therapy for ARF after cardiac surgery in 2009-2012 as a control group. The matching parameters were body weight and risk adjustment for congenital heart surgery category 1. The reintubation rate within 48 h in the HFNC group tended to be lower than that in the NIV group (3{\%} vs. 17{\%}, p=0.06). The reintubation rate within 28 days was significantly lower in the HFNC group compared to the NIV group (3{\%} vs. 26{\%}, p=0.04). The HFNC group's ICU stays were significantly shorter than those of the NIV group: 10 (IQR: 7-17) days vs. 17 (11-32) days, p=0.009. HFNC therapy might be associated with a reduced reintubation rate in children with ARF after cardiac surgery.",
keywords = "acute respiratory failure, congenital heart disease, high-flow nasal cannula, noninvasive ventilation, reintubation",
author = "Naohiro Shioji and Tomoyuki Kanazawa and Tatsuo Iwasaki and Kazuyoshi Shimizu and Tomohiko Suemori and Yasutoshi Kuroe and Hiroshi Morimatsu",
year = "2019",
month = "2",
day = "1",
doi = "10.18926/AMO/56454",
language = "English",
volume = "73",
pages = "15--20",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "1",

}

TY - JOUR

T1 - High-flow Nasal Cannula Versus Noninvasive ventilation for Postextubation Acute Respiratory Failure after Pediatric Cardiac Surgery

AU - Shioji, Naohiro

AU - Kanazawa, Tomoyuki

AU - Iwasaki, Tatsuo

AU - Shimizu, Kazuyoshi

AU - Suemori, Tomohiko

AU - Kuroe, Yasutoshi

AU - Morimatsu, Hiroshi

PY - 2019/2/1

Y1 - 2019/2/1

N2 - We compared the reintubation rate in children who received high-flow nasal cannula (HFNC) therapy to the rate in children who received noninvasive ventilation (NIV) therapy for acute respiratory failure (ARF) after cardiac surgery. This was a retrospective analysis of 35 children who received HFNC therapy for ARF after cardiac surgery in 2014-2015 (the HFNC group). We selected 35 children who had received NIV therapy for ARF after cardiac surgery in 2009-2012 as a control group. The matching parameters were body weight and risk adjustment for congenital heart surgery category 1. The reintubation rate within 48 h in the HFNC group tended to be lower than that in the NIV group (3% vs. 17%, p=0.06). The reintubation rate within 28 days was significantly lower in the HFNC group compared to the NIV group (3% vs. 26%, p=0.04). The HFNC group's ICU stays were significantly shorter than those of the NIV group: 10 (IQR: 7-17) days vs. 17 (11-32) days, p=0.009. HFNC therapy might be associated with a reduced reintubation rate in children with ARF after cardiac surgery.

AB - We compared the reintubation rate in children who received high-flow nasal cannula (HFNC) therapy to the rate in children who received noninvasive ventilation (NIV) therapy for acute respiratory failure (ARF) after cardiac surgery. This was a retrospective analysis of 35 children who received HFNC therapy for ARF after cardiac surgery in 2014-2015 (the HFNC group). We selected 35 children who had received NIV therapy for ARF after cardiac surgery in 2009-2012 as a control group. The matching parameters were body weight and risk adjustment for congenital heart surgery category 1. The reintubation rate within 48 h in the HFNC group tended to be lower than that in the NIV group (3% vs. 17%, p=0.06). The reintubation rate within 28 days was significantly lower in the HFNC group compared to the NIV group (3% vs. 26%, p=0.04). The HFNC group's ICU stays were significantly shorter than those of the NIV group: 10 (IQR: 7-17) days vs. 17 (11-32) days, p=0.009. HFNC therapy might be associated with a reduced reintubation rate in children with ARF after cardiac surgery.

KW - acute respiratory failure

KW - congenital heart disease

KW - high-flow nasal cannula

KW - noninvasive ventilation

KW - reintubation

UR - http://www.scopus.com/inward/record.url?scp=85062429568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062429568&partnerID=8YFLogxK

U2 - 10.18926/AMO/56454

DO - 10.18926/AMO/56454

M3 - Article

VL - 73

SP - 15

EP - 20

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 1

ER -